Development of hematopoietic cell lineages is tightly controlled by environmental signals, such as cytokines and growth factors. However, little is known about the cell signaling mechanisms by which the hematopoiesis at different stages is regulated by environmental cues. Much attention has been paid to transcription factors that are predominantly expressed in various types of blood cells. The focus of this project is on dissecting the function of Shp-2 in the control of hematopoietic cell development. Murine Shp-2 is a widely expressed cytoplasmic tyrosine phosphatase that was originally cloned by this applicant. Work accomplished in the previous funding period has demonstrated a critical role of Shp-2 in genesis of all blood cell lineages. This is the first example that a cytoplasmic tyrosine phosphatase acts to promote hematopoietic stem/progenitor cell commitment and differentiation. To elucidate the physiological functions of Shp-2 in various types of blood cells, we have generated a conditional Shp-2 knockout (Shp-2flox) allele using the Cre-loxP system. Experiments designed in this competing renewal proposal are to test the hypothesis that Shp-2 plays unique and different functions in lymphoid, myeloid and erythroid cell lineages.
Our specific aims are: 1) to assess the role of Shp-2 in T lymphocyte development; 2) to investigate the Shp-2 function in TCR signaling; 3) to determine the requirement of Shp-2 for sustained blood cell production; and 4) to establish and characterize ES cells with a null mutation in the Shp-2 gene. Completion of this work will lead to a better understanding of blood cell development and malignant disorders in the hematopoietic compartment. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA078606-10
Application #
7359600
Study Section
Hematopoiesis Study Section (HP)
Program Officer
Mufson, R Allan
Project Start
1999-05-01
Project End
2009-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
10
Fiscal Year
2008
Total Cost
$301,083
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Liu, Jacey J; Li, Yanjie; Chen, Wendy S et al. (2018) Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic ?-Catenin, PIK3CA and MET. J Hepatol 69:79-88
Yu, Jianxiu; Zhang, Sharon S; Saito, Kan et al. (2009) PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J 28:21-33
Wu, Dongmei; Pang, Yuhong; Ke, Yuehai et al. (2009) A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase. PLoS One 4:e4914
Mitra, Sayan; Beach, Carol; Feng, Gen-Sheng et al. (2008) SHP-2 is a novel target of Abl kinases during cell proliferation. J Cell Sci 121:3335-46
Pan, Yi; Carbe, Christian; Powers, Andrea et al. (2008) Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 135:301-10
Ke, Yuehai; Zhang, Eric E; Hagihara, Kazuki et al. (2007) Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality. Mol Cell Biol 27:6706-17
Ke, Y; Wu, D; Princen, F et al. (2007) Role of Gab2 in mammary tumorigenesis and metastasis. Oncogene 26:4951-60
Chan, Rebecca J; Feng, Gen-Sheng (2007) PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase. Blood 109:862-7
Feng, Gen-Sheng (2007) Shp2-mediated molecular signaling in control of embryonic stem cell self-renewal and differentiation. Cell Res 17:37-41
Ke, Yuehai; Lesperance, Jacqueline; Zhang, Eric E et al. (2006) Conditional deletion of Shp2 in the mammary gland leads to impaired lobulo-alveolar outgrowth and attenuated Stat5 activation. J Biol Chem 281:34374-80

Showing the most recent 10 out of 20 publications